News

Global demand for liquefied natural gas (LNG) will increase by 60% by 2040, according to Shell's LNG Outlook 2025, released today. The growth forecast is driven mainly by economic growth in Asia, industrial emissions reduction initiatives and energy requirements for artificial intelligence technologies. Industry analysts now estimate that LNG demand will reach between 630-718 million tonnes annually by 2040, an upward revision from previous estimates. This comes as global LNG trade grows by just 2 million tonnes to 407 million tonnes in 2024, marking the slowest annual growth in ten years due to limited new supply growth. "The world will need more gas for power generation, heating and cooling, industry and transport to meet growth and decarbonisation targets," said Tom Summers, seni...

Gland Pharma shares rose nearly 5 percent on February 25, its best day in 16 weeks, ahead of its investor meet during the analyst day with Emkay and BOB Capital on February 27-28. Business daily Livemint had reported in February quoting sources that Blackstone, Brookfield and Warburg Pincus were in talks to acquire a majority stake in generic injectables maker Gland Pharma. The deal between the three global private equity majors and Shanghai-based Fosun Pharma - which owns a majority stake - is expected to value Gland Pharma at around $3 billion. Gland Pharma's performance in the December quarter has been disappointing, with revenue growth in its core business being weak. The injectables company also faced challenges from its recently acquired Senexi business, which impacted its ...

Shares of drugmaker, Pfizer Ltd outperformed in an otherwise weak market. The stock of the multinational drugmaker listed on Indian exchanges rose 9% and hit an intraday high of ₹4,477 on the NSE after the company on Friday announced that it has entered into a marketing and supply agreement with Mylan Pharmaceuticals Pvt Ltd. Pfizer said it has entered into an agreement with Mylan for a period of five years to market and sell two brands Ativan and Pacitane in India. Ativan is a drug used to treat anxiety in adults and children aged 12 years and above. It also treats insomnia caused by anxiety in adults while Pacitane is indicated to treat Parkinson's disease and extrapyramidal symptoms. "Mylan has a strong presence in the central nervous system therapy space, with skilled resources ...

NHPC shares on Friday rose over 10 per cent for the third consecutive session, surging over 10 per cent following positive brokerage reports on the state-owned hydropower firm. NHPC shares rose nearly 3 per cent to hit an intraday high of Rs 82.16. This is the third consecutive day the stock is trading in the green. On Thursday, the stock gained 6.94 per cent. Over 2.57 crore shares of the stock were exchanged today, taking the total turnover to Rs 209.35 crore, as per NSE data. This sharp surge was witnessed after CLSA upgraded the stock from 'perform' to 'outperform' rating, indicating positive levers for growth. In an exclusive interview to Moneycontrol, Raj Kumar Chaudhary, chairman and managing director of the public sector undertaking (PSU), told NHPC that it will commissio...

LIC Share Price: Shares of Life Insurance Corporation of India (LIC) rose nearly 1% to ₹765 per share on the BSE on Wednesday, February 19, as the state-owned life insurer on Tuesday launched a single premium Smart Pension Plan that offers a variety of annuity options for single life as well as joint life type of annuity. A joint life insurance policy covers two individuals under one plan, while an individual policy covers only one person. Joint life annuity can be taken between any two descendants/ascendants of the family (i.e. grandparents, parents, children, grandchildren) or spouses or siblings or parents-in-law, LIC said. Single premium insurance is a life insurance plan for which the total premium has to be paid in one go and the policy has to be continued till maturity. ...

New Delhi, February 17 Shares of GlaxoSmithKline Pharmaceuticals jumped nearly 16 percent on Monday as the company reported a five-fold jump in net profit to Rs 229 crore for the third quarter ended December 31, 2024. The stock jumped 15.59 percent to close at Rs 2,332.25 on the BSE. It rose 20 percent to Rs 2,421.30 during the day. It rose 15.90 percent to Rs 2,339 on the NSE. The pharmaceutical company reported a net profit of Rs 45 crore in the October-December quarter of the previous fiscal. Revenue from operations rose to Rs 949 crore in the third quarter as against Rs 805 crore in the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a statement on Friday. Bhushan Akshikar, MD, GlaxoSmithKline Pharmaceuticals said, "Our strong third quarter results refle...

According to real estate data analytics firm PropEquity, home sales in Jaipur grew only 5 per cent in 2024 to 10,695 units, but in value terms it grew 39 per cent to Rs 8,388 crore. In 2023, home sales in the Rajasthan capital stood at 10,187 units, valued at Rs 6,019 crore, data from PropEquity showed. Sameer Jasuja, founder of PropEquity, attributed the rise in sales value to rising input costs of real estate projects due to increase in land, labour and construction material prices. Also, developers are launching more premium and luxury housing projects, leading to a rise in sales value. PropEquity recently released data for 15 major tier-2 cities, where total housing sales grew 4 per cent to 1,78,771 units in 2024 from 1,71,903 units in the previous year. In terms of val...

Aditya Birla Fashion and Retail Ltd (ABFRL) narrowed its net loss to ₹51.3 crore in Q3 FY24 from ₹77.9 crore in Q3 FY23 on the back of improvement in its revenue and profitability. Revenue from operations grew 3.3% year-on-year to ₹4,304.7 crore as against ₹4,166.7 crore last year, enabled by consistent demand across the brand portfolio.EBITDA grew 14.8% to ₹635 crore as against ₹553.2 crore, reflecting improved operating performance. EBITDA margin stood at 14.8% as compared to the same period last year when it was 13.3%, reflecting higher cost efficiency and improved profitability.Aditya Birla Fashion and Retail Ltd (ABFRL), which owns brands such as Louis Philippe, Van Heusen and Pantaloons, plans to drive future growth by enhancing its premium and digital-first offerings.On the Nationa...

Lux Industries Q3 Results: Lux Industries on Thursday, February 13 reported a 58.63% year-on-year rise in its consolidated net profit for the October-December quarter of the 2024-25 financial year (Q3 FY25) to ₹32.06 crore. The company's net profit stood at ₹20.21 crore in the same period last year. The increase in net profit was due to increase in income and reduction in expenses. Its total income stood at ₹556.87 crore in the third quarter of the financial year 2024-25, a growth of 22.48% from ₹454.65 crore in the third quarter of the 2023-24 financial year (Q3 FY24). The company's revenue from sale of products and services grew 22.2% to ₹549.34 crore during the period under review, as against ₹449.55 crore in Q3 FY2024. Lux Industries' total expenses in Q3 FY2025 stood at ₹514...

New Delhi, Feb 11: Real estate company Signature Global's sales jumped 2.8 times to a record Rs 8,670 crore in the first nine months of this fiscal on the back of strong housing demand.In the latest investor report, Signature Global projected pre-sales or sales contemplated at Rs 8,670 crore for the April-December period of FY2024-25, up from Rs 3,120 crore in the year-ago period, registering a 178 per cent annual growth.Signature Global has set a sales target of Rs 10,000 crore for the full fiscal 2024-25, up from Rs 7,270 crore in the previous fiscal.Signature Global has set a target of Rs 13,500 crore in the first nine months of this fiscal, while targeting Rs 16,000 crore for the entire 2024-25.Company Supervisor Pradeep Kumar Agarwal said that the first nine months of FY25 have been ...